Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to treat a rare progressive lung disease for which there is no known cause or cure. The new drug has yet to be approved, but in small clinical trials has shown impressive efficacy in treating idiopathic pulmonary fibrosis (IPF).